Table 4 Adverse events
Variable | GHM (n = 80) | CHM (n = 80) | P value |
|---|---|---|---|
AE | 48 (60) | 48 (60) | 0.369 |
ADE | 0 | 0 | – |
SAE | 0 | 1 (1.25) | 0.999 |
30-day mortality | 0 | 1 (1.25) | 0.999 |
Cardiogenic shock | 1 (1.25) | 0 | 0.999 |
Postoperative myocardial infarction | 1 (1.25) | 0 | 0.999 |
Repeated revascularization | 0 | 0 | – |
Fever | 16 (20.0) | 10 (12.5) | 0.237 |
Infection, reported by culture study | 8 (10.0) | 14 (17.5) | 0.225 |
Sepsis | 0 | 1 (1.25) | 0.999 |
Pneumonia | 4 (5.0) | 6 (7.5) | 0.359 |
Wound, sternum | 0 | 0 | – |
Wound, leg | 2 (2.5) | 6 (7.5) | 0.179 |
Urinary tract | 2 (2.5) | 2 (2.5) | 0.999 |
Pleural effusion requiring chest tube drainage | 6 (7.5) | 2 (2.5) | 0.179 |
Pericardial effusion requiring pericardiocentesis | 0 | 2 (2.5) | 0.999 |
New onset arrhythmia | 4 (5.0) | 0 | 0.494 |
Stroke | 0 | 0 | – |
Seizure | 0 | 2 (2.5) | 0.999 |
Gastrointestinal tract bleeding | 0 | 2 (2.5) | 0.999 |
Nausea | 24 (30.0) | 22 (27.5) | 0.999 |
Vomiting | 2 (2.5) | 2 (2.5) | 0.999 |